Compliance Fellow
Maisha MedsMaisha Meds is hiring! We’re looking for a compliance fellow to help us ensure adoption of security and compliance best practices for patient data at the last mile!
Our main product is an Android app that both operates as a point-of-sale tool and helps pharmacies manage their inventory and restock products. Our app is used by hundreds of pharmacies in Kenya, Ethiopia, and Tanzania to support hundreds of thousands of patients every year. We're rapidly expanding our user base, and are planning on expanding to more countries this year!
We also launched a program to help subsidize medicine for patients and reward providers for better medical practices. We’ve helped thousands of patients in the past couple of months and we’re aiming to reach significantly more.
The Maisha Meds Fellowship Program is a unique, one-year, on-site engagement in East Africa. Our fellows lead initiatives which influence regional healthcare practices and patient outcomes. The program is designed to employ the talents of vaccinated professionals who’d like a change of scenery after a year of working from home. Maisha Meds covers fellows’ living expenses in East Africa, including a small stipend, and offers the flexibility to work from the Kenyan coast, the Maasai Mara, or other locations, as desired.
We’re looking for a fellow to lead our compliance initiative. Our ideal candidate is knowledgeable about the healthcare space, can build processes, and provide training to help our organization become HIPAA and ISO compliant.
About Maisha Meds
Maisha Meds is an organisation dedicated to improving health care in Africa. We began full-time operations in 2017 and over the past few years has grown to support over 4 million patient encounters at over 1,200 pharmacies and drug shops annually across Kenya, Tanzania, Uganda, Nigeria, and Zambia. We are building the financial and technology infrastructure to enable global health funders to pay for health outcomes at the last mile, with an initial focus on malaria case management. Recent results from a randomised controlled trial with UC Berkeley showed that our programs lead to a statistically significant 350% increase in appropriate and high quality malaria care. Based on these results, we are planning to scale the technology to reach over 10,000 health facilities and 20 million patients, and to directly pay for health outcomes for 1 million patients annually by 2024. In addition, we are actively building programs to support injectable contraceptives, HIV pre-exposure prophylaxis, measles and HPV vaccines, malnutrition support, and safe water interventions.
Our work is funded by USAID Development Innovation Ventures, the Bill & Melinda Gates Foundation, the Children’s Investment Fund Foundation, Grand Challenges Canada, Pfizer, and others, and we are starting to build partnerships with multilateral global health funders, pharmaceutical companies, and national health insurance funds to have them pay us on a contract basis for health outcomes. We use data from our point of sale software to design programs that leverage financial incentives to improve uptake of high impact health products. And we measure our success by our ability to improve the quality and affordability of healthcare diagnosis, treatment, and prevention for low-income patients across Africa.